ClinicalTrials.Veeva

Menu

Prebiotic Effect on Metabolites in Crohn's Disease

C

Catholic University (KU) of Leuven

Status

Completed

Conditions

Crohn Disease

Treatments

Dietary Supplement: Oligofructose enriched inulin
Dietary Supplement: Maltodextrin

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to investigate the influence of the prebiotic oligofructose enriched inulin on the metabolite pattern in Crohn's disease patients.

Enrollment

67 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • crohn's disease

Exclusion criteria

  • severe crohn's disease (harvey bradshaw index >12)
  • pregnancy
  • history of colectomy
  • use of antibiotics 4-wks before start of the study
  • use of sulfapyridine
  • use of commercially available prebiotics and probiotics

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

67 participants in 2 patient groups, including a placebo group

Prebiotic
Active Comparator group
Treatment:
Dietary Supplement: Oligofructose enriched inulin
Placebo
Placebo Comparator group
Treatment:
Dietary Supplement: Maltodextrin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems